1. blackopsstreet
2. 7senza6
3. GeniusByTrade
4. TradeChem
5. zhiggeOS29
1.zhiggeOS29 10/18/2017
The Biggest Loser: Allergan's Patent Troubles
2.GeniusByTrade 01/10/2018
Allergan Is Set Up for Success in 2018, UBS Says
3.cspmedia 02/06/2018
Announces Positive Top Line Phase 3 Results for Ubrogepant - an Oral CGRP Receptor Antagonist for the Acute T…
4.TradeChem 09/10/2017
Reversing on the chart, possible cup and handle
5.blackopsstreet 12/01/2017
dont remind me
6.7senza6 02/01/2018
Receives FDA Approval of AVYCAZ
7.7senza6 02/09/2018
Risk Assessment Committee (PRAC)
8.TradeChem 10/18/2017
Yah, unfortunate
9.7senza6 02/07/2018
Allergan Reports Solid Finish to 2017 with 12% Increase in Fourth Quarter GAAP Net Revenues to $4.3 Billion
10.GeniusByTrade 10/19/2017
Here is what Cramer says.....
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW